RT Journal Article
SR Electronic
T1 Identification of novel pathogenic genes of childhood epileptic encephalopathies
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.07.25.23293037
DO 10.1101/2023.07.25.23293037
A1 Shi, Yi-Wu
A1 Zhang, Jian-Guo
A1 He, Na
A1 Ye, Zi-Long
A1 Li, Wen-Bin
A1 Liu, Han-Kui
A1 Liu, Zhi-Gang
A1 Shen, Nan-Xiang
A1 Qu, Xiao-Chong
A1 Fan, Cui-Xia
A1 Wang, Jie
A1 Luo, Sheng
A1 Lv, Yu-Dan
A1 Gao, Li
A1 Chen, Jing
A1 Huang, Shao-Ping
A1 Lu, Xin-Guo
A1 Yu, Jing
A1 Zhang, Jie
A1 Wang, Xiu-Xia
A1 Gao, Qu-Wen
A1 Jiang, Li
A1 Chen, Yan-Hui
A1 Qi, Hui
A1 Qiao, Jing-Da
A1 Chen, Li-Zhi
A1 Zeng, Yuan-Jin
A1 Yang, Xiao-Xue
A1 Yan, Hong-Jun
A1 Li, Cheng-Yan
A1 Zeng, Tao
A1 Min, Fu-Li
A1 Qin, Bing
A1 Xu, Hai-Qing
A1 Xu, Lin
A1 Li, Bing-Mei
A1 Yi, Yong-Hong
A1 Zhuo, Zhi-Hong
A1 Guo, Qing-Hui
A1 He, Su-Li
A1 Zhang, Hong-Wei
A1 Guan, Li-Ping
A1 Deng, Wei-Yi
A1 Ren, Xiao-Fan
A1 Zou, Dong-Fang
A1 Gu, Wei-Yue
A1 Su, Tao
A1 Liu, Xiao-Rong
A1 Qu, Yi-Bo
A1 Yang, Xin-Ping
A1 Liao, Wei-Ping
YR 2024
UL http://medrxiv.org/content/early/2024/01/05/2023.07.25.23293037.abstract
AB Background Epileptic encephalopathy is a devastating epilepsy with etiologies largely elusive, despite whole-gene/exon sequencing of large cohorts. This study targeted the genetic causes of childhood epileptic encephalopathy, typically Lennox-Gastaut syndrome (LGS) featured by age-dependent onset and characteristic clinical manifestations.Methods Trio-based whole-exome sequencing was performed in 235 LGS cases with individualized analyses on each trio by explainable inheritance origin with stratified frequency filtration and on each gene in four aspects, and specified statistical analyses including that on compound heterozygous variants with controls of 1942 asymptomatic parents. Animal models were used to validate the roles of novel candidate genes.Results We identified three novel causative genes, including SBF1 with de novo, CELSR2 with recessive, and TENM1 with X-linked recessive variants. Significantly higher excesses of de novo SBF1 variants and biallelic CELSR2 variants, aggregated variant frequencies of SBF1, CELSR2, and TENM1, and frequency of compound heterozygous CELSR2 variants in the cases were detected. Phenotype severity/outcome was correlated with the genotype of the variants in these genes. In Drosophila, knockdown of these genes showed increased seizure-like behavior and increased firing of excitatory neurons. Sbf1 knockout zebrafish showed seizure-like behavior, premature death, and increased firing of neurons. Celsr2 knockout mice showed spontaneous seizures with epileptiform discharges. Additional 42 genes were identified as novel candidate pathogenic genes with evidence of the four genetic aspects/statistics.Conclusions This study suggests SBF1, CELSR2, and TENM1 are pathogenic genes of LGS and highlights the implications of phenotype subclassification and individualized analyses protocol in identifying genetic causes of human diseases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the National Natural Science Foundation of China (grant Nos. 82171439, 82271505, and 81971216), and Guangdong Basic and Applied Basic Research Foundation (grant No. 2021A1515010986). The funders had no role in study design, data collection, and analysis, or in the decision to publish or the preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All procedures performed were in accordance with the ethical standards of the institutional committee. Ethical approval was approved by the ethics committee of the Second Affiliated Hospital of Guangzhou Medical University (approval ethics number 2020-hs-49).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data that support the findings of this study are available from the corresponding author upon reasonable request.